Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) scores 37 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $3.5, representing a 227% margin of safety. Quantitative score: 55/100. Qualitative score: 20/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full BYAH analysis on boothcheck